Romiplostim

CAS 267639-76-9 1 FDA-DMF supplierBiologic

Overview

Romiplostim is a thrombopoietin receptor agonist used to increase platelet counts in patients with chronic immune thrombocytopenia who have had an insufficient response to corticosteroids, immunoglobulins, or splenectomy. It functions as a fusion protein linking a thrombopoietin receptor-binding domain to an Fc segment of human immunoglobulin.

Therapeutic areas

Hematology

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.